Medical research

Why remdesivir does not fully stop the coronavirus

Remdesivir is the first drug against COVID-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral ...

Neuroscience

The uncharted molecular language of the brain

Neurons are responsible for receiving information from the outside world and conveying this information to the rest of our body. To work correctly, they need to communicate, which they do via synapses—specialized structures ...

Medical research

Crowdsourced virtual supercomputer revs up virus research

Gamers, bitcoin "miners" and companies large and small have teamed up for an unprecedented data-crunching effort that aims to harness idle computing power to accelerate research for a coronavirus treatment.

Neuroscience

Brain diseases with molecular diversity

Parkinson's and multisystem atrophy (MSA), both neurodegenerative diseases, are associated with the accumulation of alpha-synuclein proteins in the brain. Researchers at the German Center for Neurodegenerative Diseases (DZNE) ...

page 2 from 8